Abstract P183: Cholesterol Ester 18:2 is an Exercise Inducible Metabolite Associated With a Favorable Cardiometabolic Profile — Eric C. Leszczynski (2024) | RDL Network
Abstract P183: Cholesterol Ester 18:2 is an Exercise Inducible Metabolite Associated With a Favorable Cardiometabolic Profile
Circulation 149(Suppl_1)
Article 2024 English
Authors
EL
Eric C. Leszczynski
PD
Prasun K Dev
JB
Jacob L. Barber
Abstract
1 min read
Background: Prospective cohort studies have shown plasma cholesterol ester (CE) 18:2 is inversely associated with all-cause and cardiovascular mortality. However, less is known about the association of CE18:2 with cardiometabolic risk factors and whether it is responsive to regular exercise. Methods: A total of 193 known plasma lipids, including 11 CEs, were measured using the C8-positive LC-MS method in 671 participants from the HERITAGE Family Study (56% Female, 35% Black, 35 yrs) before and after a 20-week exercise intervention. Linear mixed models were used to test the associations of all lipids with 6 cardiometabolic traits at baseline and post-training adjusting for age, sex, and race, with post-training models also adjusted for baseline lipid and trait values. Paired t-tests were used to test the difference in CE18:2 abundance before and after exercise training. Results: Out of the 193 lipids, CE18:2 was consistently among the top 2 associations with each cardiometabolic trait at baseline ( Table 1 ). Levels of CE18:2 were inversely associated with triglycerides, visceral fat, glycA, and small LDL, while positively associated with HDL-C and insulin sensitivity. Importantly, CE18:2 abundance was increased following the exercise intervention (p=0.0003). Exercise-induced change in CE18:2 was significantly (FDR<0.05) associated with concomitant changes in all traits except visceral fat in the same directions as baseline, with CE18:2 among the top 3 associations with each training response trait ( Table 1 ). Conclusions: Plasma CE18:2 levels were associated with cardiometabolic traits in a favorable direction both before and after an exercise intervention. Thus, this plasma lipid may be an exercise inducible metabolite that is indicative of improvements in cardiometabolic health. However, additional studies are needed to confirm the observed findings and determine the mechanisms underlying these beneficial associations.
W.A. Clarkson, Jacob L. Barber, Jeremy Robbins, Guoshuai Cai, Prashant Rao, Michael Mi, Prasun K Dev, Sujoy Ghosh, Daniel H. Katz, Clary B. Clish, Claude Bouchard, Mark A. Sarzynski, Robert E. Gerszten
Prasun K Dev, Jacob L. Barber, W.A. Clarkson, Jeremy Robbins, Prashant Rao, Michael Mi, Sujoy Ghosh, Daniel H. Katz, Clary B. Clish, Claude Bouchard, Robert E. Gerszten, Mark A. Sarzynski
William G. Hoffmann, Yan Chen, Charles S. Schwartz, Jacob L. Barber, Prasun K Dev, Riley J Reasons, Sebastian Miranda-Maravi, Bridget Armstrong, Robert E. Gerszten, Günther Silbernagel, Robert J. Konrad, Claude Bouchard, Mark A. Sarzynski
Jeremy Robbins, Matthew Herzig, Jordan Morningstar, Mark A. Sarzynski, Daniel E. Cruz, Thomas J. Wang, Yan Gao, James G. Wilson, Claude Bouchard, Tuomo Rankinen, Robert E. Gerszten
Eric C. Leszczynski, Prasun K Dev, Jacob L. Barber, Prashant Rao, Michael Mi, Sujoy Ghosh, Margery A. Connelly, Clary B. Clish, Claude Bouchard, Jeremy Robbins, Robert E. Gerszten, Mark A. Sarzynski
Discussion(0)
No comments yet. Be the first to comment.